Regenxbio Inc
NASDAQ:RGNX

Watchlist Manager
Regenxbio Inc Logo
Regenxbio Inc
NASDAQ:RGNX
Watchlist
Price: 8.97 USD 5.04% Market Closed
Market Cap: 449.6m USD

Intrinsic Value

RGNX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RGNX stock under the Base Case scenario is 28.13 USD. Compared to the current market price of 8.97 USD, Regenxbio Inc is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RGNX Intrinsic Value
28.13 USD
Undervaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Regenxbio Inc

Valuation History Unavailable

Historical valuation for RGNX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Regenxbio Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Regenxbio Inc

Current Assets 313.2m
Cash & Short-Term Investments 267.9m
Receivables 33.2m
Other Current Assets 12.1m
Non-Current Assets 177.7m
Long-Term Investments 4.9m
PP&E 166.6m
Other Non-Current Assets 6.2m
Efficiency

Free Cash Flow Analysis
Regenxbio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Regenxbio Inc

Revenue
156.7m USD
Cost of Revenue
-32.7m USD
Gross Profit
124m USD
Operating Expenses
-281.4m USD
Operating Income
-157.4m USD
Other Expenses
-333k USD
Net Income
-157.7m USD
Fundamental Scores

RGNX Profitability Score
Profitability Due Diligence

Regenxbio Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROE
20/100
Profitability
Score

Regenxbio Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

RGNX Solvency Score
Solvency Due Diligence

Regenxbio Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
54/100
Solvency
Score

Regenxbio Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RGNX Price Targets Summary
Regenxbio Inc

Wall Street analysts forecast RGNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGNX is 33.58 USD with a low forecast of 12.12 USD and a high forecast of 54.6 USD.

Lowest
Price Target
12.12 USD
35% Upside
Average
Price Target
33.58 USD
274% Upside
Highest
Price Target
54.6 USD
509% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Regenxbio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RGNX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RGNX Insider Trading
Buy and sell transactions by insiders

RGNX News

Other Videos
What is the Intrinsic Value of one RGNX stock?

The intrinsic value of one RGNX stock under the Base Case scenario is 28.13 USD.

Is RGNX stock undervalued or overvalued?

Compared to the current market price of 8.97 USD, Regenxbio Inc is Undervalued by 68%.

Back to Top